Janux Therapeutics, Inc. · NASDAQ:JANX

Paradigm Biocapital Advisors LP's stake in Janux Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Paradigm Biocapital Advisors LP's stake in Janux Therapeutics, Inc. fell to 4.90%, 2,920,258 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
4.90%
Shares
2,920,258
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP4.90%2,920,258
Paradigm BioCapital Advisors GP LLC4.90%2,920,258
Senai Asefaw, M.D.4.90%2,920,258
Paradigm BioCapital International Fund Ltd.4.40%2,593,376

Source

View original at SEC

Related